Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

An Emerging Therapy for Dengue


Affiliations
1 Ashokrao Mane College of Pharmacy, Peth-Vadgoan. Kolhapur, Maharashtra, (416112), India
     

   Subscribe/Renew Journal


This project aims to perform the first molecular and clinical-epidermiological analysis of dengue cases in Divipolis, MG, Brazil. Where Data from 4,110 cases of dengue studied and 190 clinical samples were collected for molecular analysis. In this study, 2.7%of men and 3.0% of the women are submitted in hospital. There was no association between gender and hospital admission according to the study of health ministry fever was present in 82.2% and not present in 100%of cases. Dengue fever is a serious viral disease caused by four closely related serotytpe of the genus flavivirus, which is a family flaviviridae. Several classes of agents are in under investigation as potential antidengue drugs, including direct host modulators, antivirals, and RNA therapeutics. These antidengue drugs in development will be reviewed here. 


Keywords

Emerging Therapy, Dengue
Subscription Login to verify subscription
User
Notifications
Font Size


  • Tayade M.R, Shinkar D.M, Patil P.B, Saudagar R.B. International Journal of Current Pharmacuetical Research, doi.org/10.22159/ijcpr.2018v10i2.25848.
  • Cameron P Simmons, in Infectious Diseases (Third Edition), 2010.
  • María G. Guzman, Ana B. Perez, in International Encyclopedia of Public Health (Second Edition), 2017.
  • file:///C:/Users/Admin/Documents/EMERGING_THERAPY_FOR_DENGUE
  • https://www.researchgate.net/profile/Peter-Hill4/publication/23974505_Development_of_a_Framework_for_Eval uating_the_Sustainability_of_Community based_Dengue_Control_Projects/links/0c960517f09774fa1700000 0/Development-of-a-Framework-for-Evaluating-the- Sustainability-of-Community-based-Dengue-Control-Projects.pdf
  • https://www.who.int/news-room/q-a-detail/dengue-vaccines
  • https://www.dettol.co.in/en/illness-prevention/illnesses/everything-you-need-to-know-about-dengue/?gclid=Cj0KCQjwub- HBhCyARIsAPctr7zwb_eGG2HXMom2Xcw4bpsV4NV4_ijV5D 5MKFMM7B0gcdbfdi1d1mgaAtCxEALw_wcB&gclsrc=aw.ds
  • Dengue Virus Net. "Aedes aegypti." Dengue transmission by Aedes aegypti mosquito (2011).
  • https://www.cdc.gov/dengue/resources/factsheets/mosquitolifecycl efinal.pdf
  • Nazia Afreen, Irshad H. Naqvi, Shobha Broor, Anwar Ahmed, Shama Parveen, Phylogenetic and Molecular Clock Analysis of Dengue Serotype 1 and 3 from New Delhi, India 2015 doi.org/10.1371/journal.pone.0141628.
  • https://journals.asm.org/doi/full/10.1128/JVI.79.8.5116-5128.2005
  • https://journals.asm.org/doi/full/10.1128/JVI.79.8.5116-5128.2005
  • Research Article | Open Access Volume 2012 |Article ID 251482 |16. https://www.who.int/news-room/q-a-detail/dengue-vaccines
  • https://www.who.int/news-room/q-a-detail/dengue-vaccines

Abstract Views: 121

PDF Views: 0




  • An Emerging Therapy for Dengue

Abstract Views: 121  |  PDF Views: 0

Authors

Snehal D. Kothavale
Ashokrao Mane College of Pharmacy, Peth-Vadgoan. Kolhapur, Maharashtra, (416112), India
S.S. Suryawanshi
Ashokrao Mane College of Pharmacy, Peth-Vadgoan. Kolhapur, Maharashtra, (416112), India
Sachinkumar V. Patil
Ashokrao Mane College of Pharmacy, Peth-Vadgoan. Kolhapur, Maharashtra, (416112), India

Abstract


This project aims to perform the first molecular and clinical-epidermiological analysis of dengue cases in Divipolis, MG, Brazil. Where Data from 4,110 cases of dengue studied and 190 clinical samples were collected for molecular analysis. In this study, 2.7%of men and 3.0% of the women are submitted in hospital. There was no association between gender and hospital admission according to the study of health ministry fever was present in 82.2% and not present in 100%of cases. Dengue fever is a serious viral disease caused by four closely related serotytpe of the genus flavivirus, which is a family flaviviridae. Several classes of agents are in under investigation as potential antidengue drugs, including direct host modulators, antivirals, and RNA therapeutics. These antidengue drugs in development will be reviewed here. 


Keywords


Emerging Therapy, Dengue

References